Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
Research output: Contribution to journal › Article › Academic › peer-review
23Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial'. Together they form a unique fingerprint.